<- Go home

Added to YB: 2026-02-13

Pitch date: 2026-02-08

SRT.DE [neutral]

Sartorius Aktiengesellschaft

+1.19%

current return

Author Info

No bio for this author

Company Info

Sartorius Aktiengesellschaft provides bioprocess solutions, and lab products and services worldwide. The company offers analytical solutions, such as biolayer interferometry systems, high-throughput screening by cytometry systems, process analytical technology and data analytics, cell selection and retrieval, live-cell imaging and analysis systems, and surface plasmon resonance systems; cell culture solutions, including bioreactors and fermenters, cell culture reagents, supplements and matrices, nucleic acid and delivery solutions, cell culture media, and cell lines and buffers; and fluid management products.

Market Cap

EUR 14.5B

Pitch Price

EUR 185.20

Price Target

N/A

Dividend

0.31%

EV/EBITDA

20.60

P/E

N/A

EV/Sales

5.45

Sector

Life Sciences Tools and Services

Category

growth

Show full summary:
SGA International Growth Portfolio Holding: Sartorius Aktiengesellschaft

SRT.DE (holding update): Q3 sales +10% CC, EPS +27% on bioprocessing recovery (80% sales, +11% CC growth) as consumables rebound from post-pandemic destocking & equipment stabilizes. Lab products (R&D) weak. Mgmt raised FY guidance on improving biopharma outlook. High recurring revenue, strong position, innovation support high-teens EPS growth est. over 3yrs.

Read full article (1 min)